Hilliard Lyons

According to a research report published this morning, Hilliard Lyons has increased PDC Energy's (NASDAQ: PETD) PT from $40 to $44. In the report, Hilliard Lyons said, "PDC reported Q1'12 adjusted operating EPS of $0.06 vs. a loss of $0.12 a year ago. Our estimate was for EPS of $0.15 while...

Listed below are Benzinga's Top Upgrades today at Benzinga: ISI Group Upgrades SL Green Realty (NYSE: SLG) to Buy: ISI Group writes, "We are upgrading SLG to Buy from Hold, and increasing our price target to $89 (up from $80), as we believe the company's portfolio and management team are likely...

Hilliard Lyons has published a research report on Tempur-Pedic (NYSE: TPX) and has upgraded the company from Neutral to Long-term Buy. after the company released 1Q earnings. In the report, Hilliard Lyons writes, "With the shares having fallen ~10% below the five-year median multiples of EV/EBITDA...

According to a research report published earlier today, Hilliard Lyons has increased Comerica's (NYSE: CMA) PT from $33 to $34. In the report, Hilliard Lyons said, “We recommend purchase of Comerica. Comerica's forte is commercial lending so it should benefit more than less specialized banks from...

Hilliard Lyons increases its price target from $685 to $725 on Buy-rated Google (NASDAQ: GOOG) following a solid quarter and stock-split announcement. Hilliard Lyons says, "We maintain our Buy rating as we continue to believe in Google's long-term advertising strategy. We believe the decline in...

Hilliard Lyons has published a research report on Approach Resources (NASDAQ: AREX) after the company reported 4Q earnings up $0.06 y/y but $0.04 below analyst estimates. In the report, Hilliard Lyons writes, "We are forecasting production volume of 2,900Mboe for 2012, partially offset by a more...

Hilliard Lyons has published a research report on National Health Investors (NYSE: NHI) and has downgraded the company from Neutral to Underperform after the company's conference call. In the report, Hilliard Lyons writes, "NHI's conference call was a relatively benign event, with no major...

Hilliard Lyons has published a research report on Sherwin-Williams (NYSE: SHW) and has downgraded the company from Long-Term Buy to Neutral after the stock price rose recently. In the report, Hilliard Lyons writes, "We feel SHW has effectively dealt with a difficult housing environment. With cost...

Hilliard Lyons has downgraded Sherwin-Williams (NYSE: SHW) from Long-Term Buy to Neutral.